Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

NCT00306254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1225

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thrombosis

Interventions

DRUG: PD 0348292
DRUG: Enoxaparin

Sponsor

Pfizer